These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23789342)

  • 1. [Apoptosis-reactivating agents for targeted anticancer therapy].
    Fil'chenkov AA
    Biomed Khim; 2013; 59(2):119-43. PubMed ID: 23789342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in understanding the cell death pathways activated by anticancer therapy.
    Kim R
    Cancer; 2005 Apr; 103(8):1551-60. PubMed ID: 15742333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can targeting apoptosis resolve the cancer saga?
    Dlamini Z; Mbita Z; Ledwaba T
    Future Oncol; 2005 Jun; 1(3):339-49. PubMed ID: 16556008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer therapeutics: Targeting the apoptotic pathway.
    Khan KH; Blanco-Codesido M; Molife LR
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis-modulating drugs for improved cancer therapy.
    Ocker M; Höpfner M
    Eur Surg Res; 2012; 48(3):111-20. PubMed ID: 22538523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.
    Reuter S; Eifes S; Dicato M; Aggarwal BB; Diederich M
    Biochem Pharmacol; 2008 Dec; 76(11):1340-51. PubMed ID: 18755156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IAP antagonists: promising candidates for cancer therapy.
    Mannhold R; Fulda S; Carosati E
    Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.
    Tan CP; Lu YY; Ji LN; Mao ZW
    Metallomics; 2014 May; 6(5):978-95. PubMed ID: 24668273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular mechanisms of action of camptothecin-type drugs.
    Legarza K; Yang LX
    Anticancer Res; 2006; 26(5A):3301-5. PubMed ID: 17094444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of death receptors--relevance in cancer therapies.
    de Thonel A; Eriksson JE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
    Lorenzo HK; Susin SA
    Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of apoptotic pathways triggered by cytotoxic agents.
    Solary E; Plenchette S; Sordet O; Rébé C; Ducoroy P; Filomenko R; Bruey JM; Droin N; Corcos L
    Therapie; 2001; 56(5):511-8. PubMed ID: 11806287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis signaling in tumor therapy.
    Fulda S; Debatin KM
    Ann N Y Acad Sci; 2004 Dec; 1028():150-6. PubMed ID: 15650241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRAIL of oncogenes to apoptosis.
    Oikonomou E; Pintzas A
    Biofactors; 2013; 39(4):343-54. PubMed ID: 23813857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis modulators as cancer therapeutics.
    Penn LZ
    Curr Opin Investig Drugs; 2001 May; 2(5):684-92. PubMed ID: 11569948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
    Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG
    Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of epothilones.
    Kolman A
    Curr Opin Investig Drugs; 2005 Jun; 6(6):616-22. PubMed ID: 15988913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?
    Villunger A; Strasser A
    Oncol Res; 1998; 10(11-12):541-50. PubMed ID: 10367935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.